The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.